Earnings summaries and quarterly performance for ALTRIA GROUP.
Executive leadership at ALTRIA GROUP.
William F. Gifford, Jr.
Detailed
Chief Executive Officer
CEO
HA
Heather A. Newman
Detailed
Senior Vice President, Chief Strategy and Growth Officer
JL
Jody L. Begley
Detailed
Executive Vice President and Chief Operating Officer
RA
Robert A. McCarter III
Detailed
Executive Vice President and General Counsel
SM
Salvatore Mancuso
Detailed
Executive Vice President and Chief Financial Officer
Board of directors at ALTRIA GROUP.
DJ
Debra J. Kelly-Ennis
Detailed
Director
ER
Ellen R. Strahlman
Detailed
Director
GM
George Muñoz
Detailed
Director
IL
Ian L.T. Clarke
Detailed
Director
KB
Kathryn B. McQuade
Detailed
Chair of the Board
MM
M. Max Yzaguirre
Detailed
Director
MM
Marjorie M. Connelly
Detailed
Director
RM
R. Matt Davis
Detailed
Director
RS
Richard S. Stoddart
Detailed
Director
VE
Virginia E. Shanks
Detailed
Director
Research analysts who have asked questions during ALTRIA GROUP earnings calls.
Bonnie Herzog
Goldman Sachs
8 questions for MO
Also covers: CASY, CCEP, CELH +21 more
Eric Serotta
Morgan Stanley
6 questions for MO
Also covers: CCEP, CELH, COCO +5 more
Matthew Smith
Analyst
6 questions for MO
Also covers: BRBR, E, GIS +14 more
FB
Faham Baig
UBS Group
4 questions for MO
Also covers: BTI, PM
DM
Damian McNeela
Deutsche Numis
3 questions for MO
Also covers: BTI, PM
Emma Rumney
Reuters
3 questions for MO
Gaurav Jain
Barclays
3 questions for MO
Also covers: BTI, PM, SW
Mirza Faham Baig
UBS
3 questions for MO
Also covers: PM
Pallav Mittal
Barclays
2 questions for MO
Also covers: SW
CE
Callum Elliott
Bernstein
1 question for MO
Also covers: HLN, PM, UL
Gerald Pascarelli
Needham & Company
1 question for MO
Also covers: AGFY, CELH, COCO +8 more
ME
Matthew Edward Smith
Stifel
1 question for MO
Also covers: SMPL
Matt Smith
Bank of America
1 question for MO
Also covers: BRBR, GIS, HAIN +8 more
Mirza Faham Ali Baig
UBS Investment Bank
1 question for MO
Recent press releases and 8-K filings for MO.
Altria reports Q4 2025 results, $8B capital returns
MO
Earnings
Guidance Update
Dividends
- Full-year 2025 adjusted diluted EPS of $5.42 (up 4.4%); Q4 non-GAAP EPS of $1.30
- 2026 adjusted EPS guided to $5.56–$5.72, implying modest, back-loaded growth
- Returned ~$8 billion to shareholders in 2025 via ~$7 billion of dividends and ~$1 billion of buybacks, while raising the dividend
- Cigarette volumes down ~10% in 2025, and next-generation products pressured by an e-vapor impairment and an NJOY import block
- CEO Billy Gifford to retire in May, succeeded by CFO Salvatore Mancuso
Jan 29, 2026, 3:16 PM
Altria reports Q4 2025 earnings
MO
Earnings
Guidance Update
Dividends
Share Buyback
- Altria returned $8 billion to shareholders in 2025, comprising $7 billion in dividends and $1 billion in share repurchases; debt/EBITDA was 2.0× as of December 31, 2025.
- Full-year 2026 adjusted diluted EPS is guided to $5.56–$5.72, representing 2.5%–5.5% growth from the 2025 EPS of $5.42.
- Smokeable products segment full-year adjusted OCI rose 1.3% to $11,064 million in 2025; Q4 adjusted OCI fell 2.4% to $2,643 million.
- Q4 cigarette volume declines moderated, with Altria’s segment down 7.0% vs. -11.0% in Q4 2024; total industry decline was 6.5%.
Jan 29, 2026, 2:00 PM
Altria reports Q4 2025 results and strategy update
MO
Earnings
Guidance Update
Product Launch
- 2025 results: full-year adjusted EPS rose 4.4% and $8 billion returned to shareholders; Q4 domestic cigarette volumes declined 7.9% (7% adjusted) and Altria recorded a $1.3 billion e-vapor impairment
- 2026 guidance: full-year Adjusted Diluted EPS of $5.56–$5.72, up 2.5%–5.5%, with growth weighted to the second half reflecting import/export ramp and product investments
- Smoke-free portfolio: FDA authorized on! PLUS Mint, Wintergreen, and Tobacco; Helix full-year on! shipments grew 11% to 177 million cans; national on! PLUS rollout planned in H1 2026
- Capital allocation: $7 billion dividends (3.9% increase) and $1 billion share repurchase (17 million shares); $1 billion remaining under program; debt / EBITDA 2.0×
Jan 29, 2026, 2:00 PM
Altria reports Q4 and full-year 2025 results
MO
Earnings
Guidance Update
Product Launch
- Adjusted diluted EPS grew 4.4% to $5.42 in 2025; returned $8 billion to shareholders via dividends and share repurchases.
- 2026 EPS guidance of $5.56–$5.72, implying 2.5%–5.5% growth, weighted to H2 as import/export (duty drawback) and smoke-free investments ramp.
- Smokable product segment delivered > $11 billion in full-year adjusted OCI, with margins up 1.8 pp to 63.4%; Q4 adjusted OCI declined 2.4% and margins contracted to 60.4% amid higher manufacturing costs.
- Oral tobacco: on! shipment volumes rose 11% to 177 million cans in 2025, with full-year retail share at 8.2%; FDA authorized on! PLUS (6 mg & 9 mg) in December, with national launch planned H1 2026.
- Smoke-free alternatives represented > 50% of the total nicotine market; e-vapor grew ~15% in 2025 (illicit disposables ~70% share), and a $1.3 billion impairment was recorded on e-vapor intangibles in Q4.
Jan 29, 2026, 2:00 PM
Altria reports Q4 and full-year 2025 results
MO
Earnings
Guidance Update
Dividends
- Full-year 2025 adjusted diluted EPS rose 4.4% and Altria returned $8 billion to shareholders, comprising $7 billion in dividends and $1 billion in share repurchases; dividend raised 3.9% marking the 60th increase in 56 years.
- Smokable products delivered $11 billion+ in adjusted OCI (63.4% margin, +1.8 ppt) for 2025; Q4 adjusted OCI declined 2.4% (60.4% margin, -0.8 ppt); domestic cigarette volumes down 7% Q4 and 9.5% FY (adjusted).
- Oral tobacco segment shipped 177 million cans in 2025 (↑11%), with adjusted OCI up 1.3% (67.9% margin) and on! retail share at 8.2%; FDA authorized on! PLUS in three variants in December, with national rollout in H1 2026.
- Recorded a $1.3 billion non-cash impairment on e-vapor intangible assets amid slower enforcement of illicit disposable e-vapor products.
- 2026 outlook: Adjusted diluted EPS guidance of $5.56–$5.72 (2.5%–5.5% growth), weighted to H2 reflecting increased import/export activity and planned smoke-free investments.
Jan 29, 2026, 2:00 PM
Altria reports Q4 2025 and full-year results
MO
Earnings
Guidance Update
Share Buyback
- Adjusted diluted EPS was $1.30 in Q4 (flat vs. prior year) and $5.42 for full-year 2025 (up 4.4%).
- Net revenues declined 2.1% to $5.846 billion in Q4 and 3.1% to $23.279 billion for the full year.
- Returned $8 billion to shareholders in 2025, comprising $7.0 billion in dividends and $1.0 billion in share repurchases; repurchased 4.8 million shares in Q4.
- Provided 2026 adjusted diluted EPS guidance of $5.56–5.72, reflecting 2.5%–5.5% growth from the 2025 base.
- Helix’s on! PLUS nicotine pouch products received FDA marketing authorizations in three flavors (mint, wintergreen, tobacco).
Jan 29, 2026, 12:04 PM
Altria reports 2025 results and 2026 EPS guidance
MO
Earnings
Guidance Update
Share Buyback
- Net revenues of $5.846 billion in Q4 2025 (down 2.1%) and $23.279 billion for full-year 2025 (down 3.1%).
- Adjusted diluted EPS of $1.30 in Q4 (flat year-over-year) and $5.42 for the full year (up 4.4%).
- Returned $8 billion to shareholders in 2025, including $7 billion in dividends and $1 billion in share repurchases, with $1 billion remaining under the repurchase program.
- 2026 guidance: full-year adjusted diluted EPS of $5.56–$5.72 (growth of 2.5–5.5% vs. 2025), with an effective tax rate of 22.5–23.5% and capital expenditures of $300–$375 million.
Jan 29, 2026, 12:00 PM
Altria Q3 2025 EPS up 3.6%, doubles share repurchase
MO
Earnings
Share Buyback
Guidance Update
- Adjusted diluted EPS rose 3.6% to $1.45, outperforming expectations despite a 3% decline in net revenues to about $6.1 billion
- Expanded its share repurchase program from $1 billion to $2 billion through 2026
- Declared its 60th consecutive dividend increase, underscoring strong shareholder returns
- Narrowed full-year 2025 adjusted EPS guidance to $5.37–$5.45, forecasting moderated Q4 performance
Oct 30, 2025, 5:27 PM
Altria reports Q3 2025 results
MO
Earnings
Guidance Update
Share Buyback
- Q3 adjusted diluted EPS grew 3.6% year-over-year, and smokeable products adjusted OCI increased 0.7% to nearly $3 billion with margins expanding to 64.4%.
- Reported domestic cigarette volumes declined 8.2% (adjusted ~9%), Marlboro’s premium share rose to 59.6%, discount brand Basic captured over half of the discount-segment growth, and cigar shipments increased 2%.
- Oral tobacco segment adjusted OCI dipped <1% while margins expanded 2.4 pp to 69.2%; ON shipment volume grew 1% to 42 million cans and ON’s retail share was 8.7% of the oral category.
- Launched premium ON+ in Florida, North Carolina, and Texas; ON+ PMTA applications included in FDA’s new oral pouch pilot; Horizon filed combined PMTA/MRTPA for Ploom heated tobacco; and initiated strategic collaboration with KT&G on international modern oral and U.S. non-nicotine products.
- Raised 2025 adjusted EPS guidance to $5.37–$5.45 (up 3.5–5%), increased the quarterly dividend 3.9% to $1.06, and expanded the share repurchase program to $2 billion through 2026.
Oct 30, 2025, 1:00 PM
Altria reports Q3 2025 earnings and shareholder returns
MO
Earnings
Dividends
Share Buyback
- Adjusted diluted EPS of $1.45, a 3.6% year-over-year increase
- Quarterly dividend raised 3.9% to $1.06 per share, totaling $5.2 billion in dividends and $712 million in buybacks YTD, with repurchase program expanded to $2 billion
- Smokeable Products segment adjusted OCI of $2,956 million, up 0.7% yoy; total industry cigarette volume declined 9.0% in Q3
- Oral Tobacco Products volume fell 9.6% yoy to 178.2 million cans, while on! shipment volume edged up to 42.2 million cans
Oct 30, 2025, 1:00 PM
Quarterly earnings call transcripts for ALTRIA GROUP.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more